Physician Assistant, Medical · Los Angeles, CA
NPI
1760969943
Since 2018
Specialty
Physician Assistant, Medical
Code 363AM0700X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1414 S Grand Ave Ste 303
Los Angeles, CA, 90015
Phone (213) 483-5940
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,479 services
Medicare patients, 2024
653
Average age 73
Drug cost, 2024
$1.1M
3,466 prescriptions
Company payments, 2025
$4,155
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dorna Yaghoobzadeh was code 99213 (office e&m - established), 800 times for 461 patients. In total Dorna Yaghoobzadeh billed 1,479 services in 15 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 800 | 461 | $69.60 | $56K |
| 99214 Office E&M - Established | Office | 205 | 166 | $100.97 | $21K |
| 99212 Office E&M - Established | Office | 204 | 157 | $38.59 | $7,871 |
| 99203 Office E&M - New | Office | 96 | 96 | $83.29 | $7,996 |
| 36415 Venipuncture Blood Collection | Office | 43 | 40 | $8.65 | $372 |
| 99204 Office E&M - New | Office | 40 | 40 | $131.50 | $5,260 |
| 99215 Office E&M - Established | Office | 20 | 16 | $142.30 | $2,846 |
| 83014 Clinical Chemistry | Office | 19 | 19 | $7.70 | $146 |
| 83013 Clinical Chemistry | Office | 19 | 19 | $66.01 | $1,254 |
| 99211 Office E&M - Established | Office | 14 | 14 | $19.20 | $269 |
By year: 2022 $96K for 1,148 services; 2023 $78K for 1,373 services; 2024 $104K for 1,479 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 43 | 40 | $8.65 | $372 |
| 83013 Clinical Chemistry | 19 | 19 | $66.01 | $1,254 |
| 83014 Clinical Chemistry | 19 | 19 | $7.70 | $146 |
Medicare prescription drug claims, 2024
In 2024, the drug Dorna Yaghoobzadeh prescribed most often to Medicare patients was Famotidine, with 707 prescriptions and refills. In total Dorna Yaghoobzadeh wrote 3,466 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 707 | 1,273 | 201 | $5,545 |
| Omeprazole Generic | 552 | 978 | 186 | $6,733 |
| Pantoprazole Sodium Generic | 223 | 379 | 63 | $2,948 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 222 | 224 | 207 | $13K |
| Motegrity Prucalopride Succinate | 174 | 227 | 52 | $118K |
| Dexlansoprazole Dr Dexlansoprazole | 165 | 245 | 41 | $39K |
| Sucralfate Generic | 147 | 172 | 40 | $7,223 |
| Linzess Linaclotide | 143 | 170 | 42 | $89K |
| Trulance Plecanatide | 101 | 112 | 31 | $65K |
| Xifaxan Rifaximin | 98 | 98 | 54 | $212K |
| Baclofen Generic | 79 | 110 | 13 | $597 |
| Dexilant Dexlansoprazole | 57 | 61 | Under 11 | $18K |
| Mesalamine Generic | 57 | 73 | Under 11 | $23K |
| Creon Lipase/Protease/Amylase | 44 | 58 | 13 | $95K |
| Zenpep Lipase/Protease/Amylase | 40 | 52 | Under 11 | $101K |
Brand drugs: - claims; generic drugs: 2,615 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dorna Yaghoobzadeh $4,155 ($4,155 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $994.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 50 | $994 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 72 | $921 |
| Janssen Biotech, Inc. JNJ | 22 | $416 |
| QOL Medical, LLC | 12 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 16 | $247 |
| Ardelyx, Inc. ARDX | 12 | $226 |
| Pfizer Inc. PFE | 12 | $222 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $213 |
| Genzyme Corporation SNY | 4 | $113 |
| Aimmune Therapeutics, Inc. | 4 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.